Relapse prevalence, symptoms, and health care engagement: Patient insights from the Multiple Sclerosis In America 2017 survey
Authors: Tara Nazareth1, Jackie Polyakov1, Ed Banfe1, Kristine Zerkowski2, Leslie Beth Herbert2
Partnering with Mallinckrodt Pharmaceuticals, this abstract was published in November 2017 showcasing data from Health Union’s Multiple Sclerosis In America 2017 survey.
The aim of this survey is to obtain direct insight into relapse prevalence, symptoms, and HCP engagement from patients with MS who responded to the Multiple Sclerosis in America (MSIA) 2017 survey.
1Mallinckrodt Pharmaceuticals, external partner
2Health Union, LLC